Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|March 6, 2019
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of TuberculosisJian Xu, Si-Yang Li, Deepak V Almeida, et al.
Plos Neglected Tropical Diseases|August 14, 2018
Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcerPaul J Converse, Deepak V Almeida, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis ChemotherapyRosemary V Swanson, Nicole C Ammerman, Bongani Ngcobo, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosisRosemary V Swanson, John Adamson, Chivonne Moodley, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivoNicole C Ammerman, Rosemary V Swanson, Asa Tapley, et al.
Nature Genetics|April 12, 2016
Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistanceChristopher A Desjardins, Keira A Cohen, Vanisha Munsamy, et al.
Plos Pathogens|February 8, 2020
Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineeringBrendon M Lee, Liam K Harold, Deepak V Almeida, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2018
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of TuberculosisNicole C Ammerman, Rosemary V Swanson, Elaine M Bautista, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
Science (New York, N.Y.)|June 6, 2015
Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycinsAngela Kling, Peer Lukat, Deepak V Almeida, et al.
Pageof 4